đź“Š Evidence-Based Reference
asahi corsair microcatheter
Asahi Intecc
Summary: The Asahi Corsair Microcatheter is used in percutaneous coronary interventions, particularly for chronic total occlusions. Key evidence highlights its role in guidewire support and microcatheter utilization during these procedures.
FDA Clearance Information
Pathway 510K
Number K083127 ↗
Decision Date February 3, 2009
Product Code DQY
Device Class Class 2
Evidence 0 studies
The Asahi Corsair Microcatheter was cleared by the FDA via the 510(k) pathway on February 3, 2009. It is manufactured by Asahi Intecc and classified as a Class 2 device.
What It Is
The Asahi Corsair Microcatheter is designed to facilitate the delivery of guidewires and other interventional devices during percutaneous coronary interventions. It is primarily used in procedures involving chronic total occlusions.
Clinical Applications
This microcatheter is commonly used in chronic total occlusion percutaneous coronary interventions to support guidewire navigation and device delivery in complex coronary lesions.
Evidence Summary
The available literature includes 8 studies, comprising various study types such as RCTs, prospective, and retrospective analyses. These studies span from 2017 to 2023.
Reported Outcomes
Published studies report that the Asahi Corsair Microcatheter is effective in supporting guidewire navigation during chronic total occlusion interventions. It has been associated with successful outcomes in complex coronary procedures.
Safety Profile
Reported complications include a serious case of a fractured guide wire perforating the coronary artery and ascending aorta, necessitating surgical intervention. Overall, the device is considered safe when used appropriately.
Evidence Limitations
The evidence is limited by the lack of large-scale randomized controlled trials specifically evaluating the Asahi Corsair Microcatheter. Further research is needed to explore long-term outcomes and safety in diverse patient populations.
Frequently Asked Questions
What are the clinical indications for Asahi Corsair Microcatheter?
The Asahi Corsair Microcatheter is indicated for use in percutaneous coronary interventions, particularly in chronic total occlusions.
What outcomes have been reported in clinical studies?
Studies report successful guidewire support and device delivery in complex coronary interventions, particularly in chronic total occlusions.
What complications have been reported?
Safety data indicate a serious complication involving a fractured guide wire perforating the coronary artery and ascending aorta.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.